메뉴 건너뛰기




Volumn 25, Issue 12, 2009, Pages 2817-2828

Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice

Author keywords

Clinical practice; LDL C; Real world study; Rosuvastatin; Statin effectiveness

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

EID: 72549114023     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903333389     Document Type: Review
Times cited : (7)

References (43)
  • 1
    • 0347453124 scopus 로고    scopus 로고
    • World Health Organization (WHO). World Health Organization 2003: Geneva, Switzerland
    • World Health Organization (WHO). World Health Report 2003 - Shaping the future. World Health Organization 2003: Geneva, Switzerland, 2003
    • (2003) World Health Report 2003 - Shaping the Future
  • 3
    • 19344364960 scopus 로고    scopus 로고
    • American Heart Association. Dallas, TX: American Heart Association
    • American Heart Association. Heart Disease and Stroke Statistics - 2009 Update. Dallas, TX: American Heart Association, 2009
    • (2009) Heart Disease and Stroke Statistics - 2009 Update
  • 4
    • 23944481875 scopus 로고    scopus 로고
    • Guidelines on cardiovascular disease prevention in clinical practice: The European perspective
    • DOI 10.1097/01.hco.0000176405.56119.54
    • Graham IM. Guidelines on cardiovascular disease prevention in clinical practice: the European perspective. Curr Opin Cardiol 2005;20:430-439 (Pubitemid 41192160)
    • (2005) Current Opinion in Cardiology , vol.20 , Issue.5 , pp. 430-439
    • Graham, I.M.1
  • 5
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 6
    • 34548329882 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice
    • Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 2007;14:S1-113
    • (2007) Eur J Cardiovasc Prev Rehabil , vol.14
    • Graham, I.1    Atar, D.2    Borch-Johnsen, K.3
  • 7
    • 0037417947 scopus 로고    scopus 로고
    • American Heart Association guide for improving cardiovascular health at the community level: A statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science
    • Pearson TA, Bazzarre TL, Daniels SR, et al. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 2003;107:645-651
    • (2003) Circulation , vol.107 , pp. 645-651
    • Pearson, T.A.1    Bazzarre, T.L.2    Daniels, S.R.3
  • 8
    • 0037118660 scopus 로고    scopus 로고
    • AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 Update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases
    • Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 Update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002;106:388-391
    • (2002) Circulation , vol.106 , pp. 388-391
    • Pearson, T.A.1    Blair, S.N.2    Daniels, S.R.3
  • 10
    • 0035949527 scopus 로고    scopus 로고
    • AHA/ACC Scientific Statement: AHA/ ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
    • Smith Jr SC, Blair SN, Bonow RO, et al. AHA/ACC Scientific Statement: AHA/ ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 2001;104:1577-1579
    • (2001) Circulation , vol.104 , pp. 1577-1579
    • Smith Jr., S.C.1    Blair, S.N.2    Bonow, R.O.3
  • 12
    • 4544275379 scopus 로고    scopus 로고
    • Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
    • Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004;44:720-732
    • (2004) J Am Coll Cardiol , vol.44 , pp. 720-732
    • Grundy, S.M.1    Cleeman, J.I.2    Merz, C.N.3
  • 13
    • 34248223741 scopus 로고    scopus 로고
    • Safety of rosuvastatin: Update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program
    • DOI 10.1159/000100908
    • Shepherd J, Vidt DG, Miller E, et al. Safety of rosuvastatin: update of 16,876 rosuvastatin-treated patients in a multinational clinical trial program. Cardiology 2007;107:433-443 (Pubitemid 46788271)
    • (2007) Cardiology , vol.107 , Issue.4 , pp. 433-443
    • Shepherd, J.1    Vidt, D.G.2    Miller, E.3    Harris, S.4    Blasetto, J.5
  • 15
    • 0036910821 scopus 로고    scopus 로고
    • Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial
    • DOI 10.1067/mhj.2002.129312
    • Brown WV, Bays HE, Hassman DR, et al. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial. Am Heart J 2002;144:1036-1043 (Pubitemid 36026917)
    • (2002) American Heart Journal , vol.144 , Issue.6 , pp. 1036-1043
    • Brown, W.V.1    Bays, H.E.2    Hassman, D.R.3    McKenney, J.4    Chitra, R.5    Hutchinson, H.6    Miller, E.7
  • 16
    • 56749106312 scopus 로고    scopus 로고
    • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207
    • (2008) N Engl J Med , vol.359 , pp. 2195-2207
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 17
    • 26844548012 scopus 로고    scopus 로고
    • Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: Results from the URANUS study
    • and the URANUS study investigators
    • Berne C, Siewert-Delle A, and the URANUS study investigators. Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study. Cardiovasc Diabetol 2005;4:7
    • (2005) Cardiovasc Diabetol , vol.4 , pp. 7
    • Berne, C.1    Siewert-Delle, A.2
  • 18
    • 34848817975 scopus 로고    scopus 로고
    • Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined c-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (<70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study)
    • Betteridge DJ, Gibson JM, Sager PT. Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined c-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (<70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study). Am J Cardiol 2007;100:1245-1248
    • (2007) Am J Cardiol , vol.100 , pp. 1245-1248
    • Betteridge, D.J.1    Gibson, J.M.2    Sager, P.T.3
  • 19
    • 20144370402 scopus 로고    scopus 로고
    • Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes - CORALL study
    • Vincent HH on behalf of the Dutch CORALL Study Group
    • Wolffenbuttel BHR, Franken AAM, Vincent HH on behalf of the Dutch CORALL Study Group. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes - CORALL study. J Int Med 2005;257:531-539
    • (2005) J Int Med , vol.257 , pp. 531-539
    • Wolffenbuttel, B.H.R.1    Franken, A.A.M.2
  • 20
    • 4344630666 scopus 로고    scopus 로고
    • Wilmington, DE: AstraZeneca Pharmaceuticals LP
    • Crestor [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP, 2003
    • (2003) Crestor [Package Insert]
  • 21
    • 33644546619 scopus 로고    scopus 로고
    • New York, NY: Pfizer Inc
    • Lipitor [package insert]. New York, NY: Pfizer Inc, 2004
    • (2004) Lipitor [Package Insert]
  • 22
    • 13644265047 scopus 로고    scopus 로고
    • Whitehouse Station, NJ: Merck & Co, Inc
    • Zocor [package insert]. Whitehouse Station, NJ: Merck & Co, Inc, 2004
    • (2004) Zocor [Package Insert]
  • 23
    • 33644558287 scopus 로고    scopus 로고
    • Princeton, NJ: Bristol-Myers Squibb Co
    • Pravachol [package insert]. Princeton, NJ: Bristol-Myers Squibb Co, 2004
    • (2004) Pravachol [Package Insert]
  • 24
    • 13644249346 scopus 로고    scopus 로고
    • East Hanover, NJ: Novartis Pharmaceuticals
    • Lescol [package insert]. East Hanover, NJ: Novartis Pharmaceuticals, 2003
    • (2003) Lescol [Package Insert]
  • 25
    • 63749103497 scopus 로고    scopus 로고
    • Whitehouse Station, NJ: Merck & Co, Inc
    • Mevacor [package insert]. Whitehouse Station, NJ: Merck & Co, Inc, 2004
    • (2004) Mevacor [Package Insert]
  • 26
    • 36549040492 scopus 로고    scopus 로고
    • In defense of pharmacoepidemiology - Embracing the yin and yang of drug research
    • Avorn J. In defense of pharmacoepidemiology - embracing the yin and yang of drug research. N Engl J Med 2007;357:2219-2221
    • (2007) N Engl J Med , vol.357 , pp. 2219-2221
    • Avorn, J.1
  • 27
    • 33845257814 scopus 로고    scopus 로고
    • Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice
    • Ohsfeldt RL, Gandhi SK, Fox KM, et al. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. Am J Manag Care 2006;12:S412-23
    • (2006) Am J Manag Care , vol.12
    • Ohsfeldt, R.L.1    Gandhi, S.K.2    Fox, K.M.3
  • 28
    • 34249098742 scopus 로고    scopus 로고
    • Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals
    • Kamat SA, Gandhi SK, Davidson MH. Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals. Curr Med Res Opin 2007;23:1121-1130
    • (2007) Curr Med Res Opin , vol.23 , pp. 1121-1130
    • Kamat, S.A.1    Gandhi, S.K.2    Davidson, M.H.3
  • 30
    • 33645682109 scopus 로고    scopus 로고
    • Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting
    • Bullano MF, Wertz DA, Yang GW, et al. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting. Pharmacotherapy 2006;26:469-478
    • (2006) Pharmacotherapy , vol.26 , pp. 469-478
    • Bullano, M.F.1    Wertz, D.A.2    Yang, G.W.3
  • 31
    • 50149117208 scopus 로고    scopus 로고
    • LDL-C reductions and goal attainment among naïve statin users in the Netherlands: Real life results
    • Heintjes EM, Hirsch MW, Linden M, et al. LDL-C reductions and goal attainment among naïve statin users in the Netherlands: real life results. Curr Med Res Opin 2008;24:2241-2250
    • (2008) Curr Med Res Opin , vol.24 , pp. 2241-2250
    • Heintjes, E.M.1    Hirsch, M.W.2    Linden, M.3
  • 32
    • 43749113805 scopus 로고    scopus 로고
    • The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal
    • DOI 10.1111/j.1742-1241.2008.01771.x
    • Harley CR, Gandhi S, Heien H, et al. The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal. Int J Clin Pract 2008;62:889-895 (Pubitemid 351691501)
    • (2008) International Journal of Clinical Practice , vol.62 , Issue.6 , pp. 889-895
    • Harley, C.R.1    Gandhi, S.2    Heien, H.3    Nelson, S.P.4
  • 33
    • 53749086313 scopus 로고    scopus 로고
    • Statin cost-effectiveness comparisons using real-world effectiveness data: Formulary implications
    • Ohsfeldt RL, Gandhi SK, Fox KM, et al. Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications. Value Health 2008;11:1061-1069
    • (2008) Value Health , vol.11 , pp. 1061-1069
    • Ohsfeldt, R.L.1    Gandhi, S.K.2    Fox, K.M.3
  • 34
    • 42049121865 scopus 로고    scopus 로고
    • A UK survey of rosuvastatin in general practice: Reaching cholesterol targets
    • 1008
    • Kassianos G, Reckless J, Emmas C, et al. A UK survey of rosuvastatin in general practice: reaching cholesterol targets. Br J Cardiol 1008;15:95-100
    • Br J Cardiol , vol.15 , pp. 95-100
    • Kassianos, G.1    Reckless, J.2    Emmas, C.3
  • 35
    • 41149180129 scopus 로고    scopus 로고
    • Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance
    • Backes JM, Venero CV, Gibson CA, et al. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance. Ann Pharmacother 2008;42:341-346
    • (2008) Ann Pharmacother , vol.42 , pp. 341-346
    • Backes, J.M.1    Venero, C.V.2    Gibson, C.A.3
  • 36
    • 34548617373 scopus 로고    scopus 로고
    • Effectiveness of statins in Medicare-eligible patients and patients565 years using clinical practice data
    • Fox KM, Gandhi SK, Ohsfeldt RL, et al. Effectiveness of statins in Medicare-eligible patients and patients565 years using clinical practice data. Int J Clin Pract 2007;61:1634-1642
    • (2007) Int J Clin Pract , vol.61 , pp. 1634-1642
    • Fox, K.M.1    Gandhi, S.K.2    Ohsfeldt, R.L.3
  • 37
    • 36048959846 scopus 로고    scopus 로고
    • Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: A retrospective study using an electronic medical records dataset in the United States
    • Fox KM, Gandhi SK, Ohsfeldt RL, et al. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. Cur Med Res Opin 2007;23:2125-2133
    • (2007) Cur Med Res Opin , vol.23 , pp. 2125-2133
    • Fox, K.M.1    Gandhi, S.K.2    Ohsfeldt, R.L.3
  • 38
    • 37849044165 scopus 로고    scopus 로고
    • Comparison of low density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in real-world clinical practice setting
    • Fox KM, Gandhi SK, Ohsfeldt RL, et al. Comparison of low density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in real-world clinical practice setting. Am J Manag Care 2007;13:S270-5
    • (2007) Am J Manag Care , vol.13
    • Fox, K.M.1    Gandhi, S.K.2    Ohsfeldt, R.L.3
  • 39
    • 35848948801 scopus 로고    scopus 로고
    • Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice
    • Harley CR, Gandhi S, Blasetto J, et al. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Am J Geriatr Pharmacother 2007;5:185-194
    • (2007) Am J Geriatr Pharmacother , vol.5 , pp. 185-194
    • Harley, C.R.1    Gandhi, S.2    Blasetto, J.3
  • 40
    • 41949105051 scopus 로고    scopus 로고
    • Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: Rosuvastatin compared with other statins in usual care
    • DOI 10.1517/14656566.9.5.669
    • Harley CR, Gandhi SK, Heien H, et al. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother 2008;9:669-676 (Pubitemid 351566187)
    • (2008) Expert Opinion on Pharmacotherapy , vol.9 , Issue.5 , pp. 669-676
    • Harley, C.R.1    Gandhi, S.K.2    Heien, H.3    McDonough, K.4    Nelson, S.P.5
  • 41
  • 42
    • 37349030074 scopus 로고    scopus 로고
    • Titration patterns with rosuvastatin as compared with other statins in clinical practice: A retrospective observational cohort study using an electronic medical record database
    • Fox KM, Gandhi SK, Ohsfeldt RL, et al. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. Clin Ther 2007;29:2385-2394
    • (2007) Clin Ther , vol.29 , pp. 2385-2394
    • Fox, K.M.1    Gandhi, S.K.2    Ohsfeldt, R.L.3
  • 43
    • 0036917270 scopus 로고    scopus 로고
    • Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice
    • DOI 10.1016/S0002-9343(02)01303-7, PII S0002934302013037
    • Frolkis JP, Pearce GL, Nambi V, et al. Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice. Am J Med 2002;113:625-629 (Pubitemid 36015797)
    • (2002) American Journal of Medicine , vol.113 , Issue.8 , pp. 625-629
    • Frolkis, J.P.1    Pearce, G.L.2    Nambi, V.3    Minor, S.4    Sprecher, D.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.